Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Fiona Kermeen"'
Autor:
David S. Celermajer, Jeremy P. Wrobel, Nathan Dwyer, Edmund M.T. Lau, Dominic Keating, Helen Whitford, P. Steele, John Feenstra, Eleni Giannoulatou, K. Whyte, Nicholas Collins, Susanna Proudman, Eugene Kotlyar, Melanie Lavender, Vivek Thakkar, Anne Keogh, Geoff Strange, Trevor Williams, Carolyn Corrigan, Fiona Kermeen
Publikováno v:
Heart, Lung and Circulation. 27:1368-1375
Background Epidemiology and treatment strategies continue to evolve in pulmonary arterial hypertension (PAH). We sought to define the characteristics and survival of patients with idiopathic, heritable and drug-induced PAH in the current management e
Autor:
David S. Celermajer, Jeremy P. Wrobel, Fiona Kermeen, John Feenstra, P. Steele, Trevor Williams, Edmund M.T. Lau, Helen Whitford, Tanya McWilliams, K. Whyte, Melanie Lavender, Bronwen Rhodes, Anne Keogh, Carolyn Corrigan, Mark Horrigan, Nathan Dwyer, James Anderson, Nicholas Collins, Dominic Keating, Raymond L. Benza, Geoff Strange, Eugene Kotlyar, Robert G. Weintraub, Vivek Thakkar
Publikováno v:
Chest. 157(1)
Pulmonary arterial hypertension (PAH) prognosis has improved with targeted therapies; however, the long-term outlook remains poor. Objective multiparametric risk assessment is recommended to identify patients at risk of early morbidity and mortality,
Publikováno v:
Respirology. 22:165-171
Background and objective The 6-min walk test (6MWT) is the most widely utilized method of assessing exercise capacity in pulmonary arterial hypertension (PAH). Cardiopulmonary exercise testing has the advantage of providing additional physiological i
Autor:
Nathan Dwyer, Hayley S. Whitford, Chris Frampton, Patrick Disney, David S. Celermajer, M. Rose, Anne Keogh, Robert G. Weintraub, Leeanne Grigg, Fiona Kermeen, Eugene Kotlyar, David Tanous, G. Strange, Clare O'Donnell, Andrew Bullock
Publikováno v:
Internal Medicine Journal. 45:944-950
Background The management of children with congenital heart disease (CHD) has improved over recent decades and several patients surviving with CHD into adulthood are increasing. In developed countries, there are now as many adults as there are childr
Publikováno v:
European Respiratory Journal. 45:1179-1182
The 6-min walk test (6MWT) is well standardised and, as per current guidelines, is deemed safe to perform in a range of patients [1]. In pulmonary arterial hypertension (PAH), 6-min walk distance (6MWD) is an important predictor of mortality and morb
Publikováno v:
The Cochrane Library
BACKGROUND: Individuals with pulmonary hypertension (PH) have reduced exercise capacity and quality of life. Despite initial concerns that exercise training may worsen symptoms in this group, several studies have reported improvements in functional c
Publikováno v:
Internal Medicine Journal. 44:114-123
On 5 May 2013 it was World Pulmonary Hypertension (PHT) Day marking three decades on from the first reported deaths in an epidemic because of toxic rapeseed (canola) oil. This epidemic provided the impetus to the first World Health Organization to se
Autor:
A. Yamada, Norman R. Morris, Christian Hamilton-Craig, Surendran Sabapathy, Marco van Kessel, Thomas Butler, David Seaton, Fiona Kermeen, Jonathan Chan
Publikováno v:
The international journal of cardiovascular imaging. 33(4)
Autor:
Dominic Keating, Carolyn Corrigan, Fiona Kermeen, M. Lavendar, David S. Celermajer, Eugene Kotlyar, Trevor Williams, Edmund M.T. Lau, P. Steele, Nicholas Collins, John Feenstra, S. Ratwatte, Vivek Thakkar, Nathan Dwyer, Anne Keogh, Jeremy P. Wrobel, Helen Whitford, K. Whyte, G. Strange, Susanna Proudman
Publikováno v:
Heart, Lung and Circulation. 28:S169
Autor:
Rachel O'Rourke, David S. Celermajer, Richard Slaughter, Fiona Kermeen, Shareen Jaijee, Wendy Strugnal, Raj Puranik
Publikováno v:
International Journal of Cardiology. Heart & Vessels
article i nfo Background: Our objective was to determine the relationship between structural changes in the heart and functional and haemodynamic changes, in subjects before and after pulmonary thromboarterectomy (PEA) for chronic thromboembolic pulm